 On March 4, 2016, Senator Al Franken introduced the Protecting Americans from Drug Marketing Act, which proposed the removal of tax breaks for pharmaceutical companies who engage in DTCA.Franken similarly showed concerns that the industry was spending too much on marketing.In a similar move, representative Rosa DeLauro called for a three-year moratorium on advertising of newly-approved prescription drugs.